ReviewClinical pharmacology and therapeutics2026

An IQ Consortium Perspective on the FDA Guidance for Assessment of Pharmacokinetics in Participants With Impaired Renal Function.

Yan Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.